Philip Morris International Inc. 2026 Third-Quarter Results - PHILIP MORRIS INTERNATIONAL INC

Explicit Guidance:

• FY2026 Full-Year Outlook:
  • Total Shipments: Expects year-end shipment growth, marking the sixth consecutive year of volume growth.
  • Net Revenue: Forecasting 5–7% organic growth; believes performance could land in the middle to upper half of this range, driven by international smoke-free momentum.
  • Operating Income (OI): Expects 7–9% organic growth. Anticipates full-year delivery to be at the midpoint or lower half of this range due to US investments and geopolitical costs.
  • EPS Growth (Currency-Neutral): Targeting 7.5–9.5% growth.
  • EPS Growth (Dollar Terms): Forecasting 10–12% growth, assuming ~$0.18 favorable currency impact. Full-year delivery likely in the midpoint or lower half ($8.29–$8.44 range) due to headwinds.
  • Operating Cash Flow: Expects to generate a record ~$13.5 billion.
• FY2026 Q4 Outlook:
  • US Operating Income: Anticipates an "abnormally low" level, with adjusted operating company income (OCI) at approximately zero or slightly negative, due to elevated investments and portfolio transition.
  • HDU Shipments: Expects 39.5–40.5 billion units for the full year, with Q4 shipment phasing consistent with this target.
  • US Revenue Impact: The transition to 20-pouch cans and promotional support will negatively impact Q4 net revenues (approx. 25% reduction in revenue per pouch all else equal).

Business-Segment Outlook:

• Smoke-Free (Global): Expecting high single-digit growth in adjusted IMS volumes and shipments for the full year (subject to year-end inventory movements). Q3 HTU shipments exceeded the high end of expectations.
• IQOS (HTU): Expects HTU shipment growth to trail adjusted IMS growth for the full year, a dynamic expected to continue in Q4 due to Japan's price changes (40 yen in April, 20 yen in October) causing consumer pantry loading.
• Japan: Excise increases in 2026 are volatile; the calendar for the next three years is projected to be less disruptive with moderate annual increases. Confidence remains in mid-term growth potential despite a likely softer Q4 as pantry loading reverses.
• Zyn (Nicotine Pouches):
  • US: Q4 shipment volumes expected to be broadly in line to modestly above Q3 levels. Full-year portfolio expansion (two waves) supports strong long-term growth. Q3 category share increased by estimated 1.4 points.
  • International: Q3 growth accelerated to +7% (ex-Nordics +30%). Continued investment behind portfolio innovation and category expansion.
• E-Vapor (Veev): Maintaining strong momentum with double-digit shipment growth (Q3 +62%, YTD +68%). Leading position in Europe, with expansion in South Korea, Egypt, and Malaysia. New "Vive Plus One" device rollout ongoing.
• Combustibles: Expects full-year pricing to remain above 8%. Full-year cigarette volume decline expected to be approximately 1.2%, similar to YTD performance. Q3 pricing reached +8.9% driven by Turkey, Philippines, Indonesia, and Poland.
• Margins: Q3 adjusted OI margin reached nearly 45%. Margins supported by strong pricing, favorable smoke-free mix, and manufacturing productivity.

Market and Competitive Outlook:

• Share Gains: International smoke-free portfolio outgrew the comparable industry by ~1 percentage point; share increased to 62%. International combustible share reached 25.9% (Marlboro at record 11.4%).
• Japan Market: Heated tobacco accounts for >50% of total nicotine offtake; substantial remaining pool of smokers yet to switch. Bonds by IQOS successfully attracting entrenched smokers.
• US Market: Zyn category share gains observed despite strong competition. New variants (Zyn Ultra, 9mg/11mg) driving inflows of competitor users and former switchers.
• Pricing Environment: Combustible pricing remains strong (high single-digit to double-digit) in key markets (Turkey, Indonesia, Poland, Germany).

Macro / Industry Outlook:

• Geopolitics & Inflation: Ongoing conflicts in the Middle East and Ukraine driving energy and input cost inflation. Estimated full-year EPS drag of ~1% (0.5% from energy/shipping costs, 0.5% from Ukraine disruptions). Q4 expected to see higher flow-through of input price increases.
• Regulatory/Tax: Japan's excise calendar for 2027 expected to be moderate (12 yen increase for both combustibles and HTUs). Argentina opening as a new market opportunity. Germany implementing significant excise tax increases starting Jan 1, 2027 (83–88 cents); PMI confident in competitiveness due to brand strength (Marlboro/L&M).
• Currency: Expected favorable impact of ~$0.18 on full-year EPS due to dollar weakness relative to the euro.

Strategic Initiatives:

• US Portfolio Expansion:
  • Wave 1: Rollout of Zyn Ultra (higher nicotine) and expanded flavor lineup for dry portfolio; approaching full distribution.
  • Wave 2: Shipments of new flagship variants (1.5mg and 8mg) began in Q3.
  • Price/Value Optimization: Transitioning flagship variants from 15 to 20 pouches at the 15-cann price point. Transition expected to complete in Q4.
  • Investment: US SG&A rose to ~$370M in Q3; Q4 expected to see an exceptional sequential increase of ~10% (total US SG&A ~$370M in Q4) to fund "When it Clicks" campaign and consumer awareness. Q3 spend level viewed as a proxy for next year's run rate.
• Manufacturing: Colorado Zyn facility ramping up production; overheads currently elevated but expected to normalize in 2027.
• International Innovation: Continued rollout of new variants for Terea, Levia, and Bonds by IQOS. Expansion of Zyn in international markets (Sweden, Poland, Mexico, etc.).

Risks and Headwinds to Outlook:

• US Q4 Profitability: Significant investment outlays and revenue dilution from the 15-to-20 pouch transition will drive US OI to near zero/negative in Q4.
• Cost Pressures: Inflationary pressures from Middle East/Ukraine conflicts could worsen in Q4 as input costs flow through.
• Regulatory Volatility: Tax changes in Japan (completed in 2026) and Germany (starting 2027) impact pricing and volume phasing.
• Supply Chain: Disruptions in Ukraine (one-off destruction of goods) impacted 2026 results; future impact uncertain if conflict continues.
• Inventory Dynamics: Japan's pantry loading/unloading creates a temporary divergence between shipment volumes and in-market sales (IMS).

Management Tone on the Future:

• Confidence: Management expresses "unwavering commitment" and "strong confidence" in the mid- and long-term trajectory, citing "best-in-class" fundamentals.
• Resilience: Highlights resilience of the business model against inflationary pressures, noting lower exposure than peers.
• Investment Stance: Views the current elevated US investment as necessary for "mid- and long-term growth" and "sustainable growth," absorbing costs via strength in other segments.
• Guidance Adjustment: Guidance adjusted downward from prior expectations to the "mid or lower half" of ranges to account for known US investment costs and geopolitical headwinds, maintaining a "best-in-class" performance expectation despite these reductions.

Miscellaneous:

• Dividend: Raised dividend for the 19th consecutive year to $6.40 per share (approx. 9% increase).
• Investor Day: Planned for Q2 of the following year.
• Share Count/Buybacks: No specific new buyback guidance provided in this segment, though focus remains on deleveraging and shareholder returns.